Involvement of resistin-like molecule β in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Okubo, Hirofumi ^a   Kushiyama, Akifumi ^b   Sakoda, Hideyuki ^c   Nakatsu, Yusuke ^a   Iizuka, Masaki ^d   Taki, Naoyuki ^d   Fujishiro, Midori ^c   Fukushima, Toshiaki ^a   Kamata, Hideaki ^a   Nagamachi, Akiko ^e   Inaba, Toshiya ^e   Nishimura, Fusanori ^a   Katagiri, Hideki ^f   Asahara, Takashi ^g   Yoshida, Yasuto ^g   Chonan, Osamu ^g   Encinas, Jeffery ^d   Asano, Tomoichiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HORMONE; METHIONINE; RETNLB PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL; COLON; DEFICIENCY; DIET; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; INTESTINE FLORA; KNOCKOUT MOUSE; KUPFFER CELL; LIVER; MACROPHAGE; MALE; METABOLISM; MOUSE; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; VITAMIN DEFICIENCY;

ANIMALS; BIOMARKERS; CHOLINE DEFICIENCY; COLON; DIET; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION; HORMONES, ECTOPIC; KUPFFER CELLS; LIVER; MACROPHAGES; MALE; METHIONINE; MICE; MICE, KNOCKOUT; NON-ALCOHOLIC FATTY LIVER DISEASE; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC;

EID: 84961352367     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20157     Document Type: Article

References (41)

1. Chitturi, S. & Farrell, G. C. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21, 27-41 (2001).
2. Malaguarnera, M., Di Rosa, M., Nicoletti, F. & Malaguarnera, L. Molecular mechanisms involved in NAFLD progression. J Mol Med 87, 679-695 (2009).
3. Day, C. P. & James, O. F. Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845 (1998).
4. Miele, L. et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877-1887 (2009).
5. Shanab, A. A. et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci 56, 1524-1534 (2011).
6. Imajo, K., Yoneda, M., Ogawa, Y., Wada, K. & Nakajima, A. Microbiota and nonalcoholic steatohepatitis. Semin Immunopathol 36, 115-132 (2014).
7. Steppan, C. M. et al. The hormone resistin links obesity to diabetes. Nature 409, 307-312 (2001).
8. Banerjee, R. R. & Lazar, M. A. Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J Biol Chem 276, 25970-25973 (2001).
9. Patel, S. D., Rajala, M. W., Rossetti, L., Scherer, P. E. & Shapiro, L. Disulfide-dependent multimeric assembly of resistin family hormones. Science 304, 1154-1158 (2004).
10. Kushiyama, A. et al. Resistin-like molecule beta is abundantly expressed in foam cells and is involved in atherosclerosis development. Arterioscler Thromb Vasc Biol 33, 1986-1993 (2013).
11. He, W. et al. Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology 125, 1388-1397 (2003).
12. Wang, M. L. et al. Regulation of RELM/FIZZ isoform expression by Cdx2 in response to innate and adaptive immune stimulation in the intestine. Am J Physiol Gastrointest Liver Physiol 288, G1074-G1083 (2005).
13. Herbert, D. R. et al. Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med 206, 2947-2957 (2009).
14. Hildebrandt, M. A. et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716-1724+e1711-e1712 (2009).
15. Rajala, M. W., Obici, S., Scherer, P. E. & Rossetti, L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 111, 225-230 (2003).
16. Hu, W. L., Qiao, S. B., Hou, Q. & Yuan, J. S. Plasma resistin is increased in patients with unstable angina. Chin Med J 120, 871-875 (2007).
17. Takeishi, Y. et al. Serum resistin is associated with high risk in patients with congestive heart failure-a novel link between metabolic signals and heart failure. Circ J 71, 460-464 (2007).
18. Nair, M. G. et al. Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation. J Immunol 181, 4709-4715 (2008).
19. McVay, L. D. et al. Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest 116, 2914-2923 (2006).
20. Hogan, S. P. et al. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol 118, 257-268 (2006).
21. Barnes, S. L. et al. Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis. J Immunol 179, 7012-7020 (2007).
22. Krimi, R. B. et al. Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice. Inflamm Bowel Dis 14, 931-941 (2008).
23. Kushiyama, A. et al. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J Biol Chem 280, 42016-42025 (2005).
24. Miquilena-Colina, M. E. et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut 60, 1394-1402 (2011).
25. Memon, R. A., Feingold, K. R., Moser, A. H., Fuller, J. & Grunfeld, C. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol 274, E210-E217 (1998).
26. Iredale, J. P. Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol 29, 43-54 (1997).
27. Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M. & Diehl, A. M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94, 2557-2562 (1997).
28. Miura, K., Seki, E., Ohnishi, H. & Brenner, D. A. Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. Gastroenterol Res Pract 2010, 362847 (2010).
29. Cani, P. D. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103 (2009).
30. Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481 (2008).
31. Klein, I. et al. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110, 4077-4085 (2007).
32. Takahashi, Y., Soejima, Y. & Fukusato, T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 18, 2300-2308 (2012).
33. Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772 (2007).
34. Montalto, M. et al. Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells. Digestion 69, 225-228 (2004).
35. Ahrne, S. & Hagslatt, M. L. Effect of lactobacilli on paracellular permeability in the gut. Nutrients 3, 104-117 (2011).
36. Okubo, H. et al. Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. Am J Physiol Gastrointest Liver Physiol 305, G911-G918 (2013).
37. Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321 (2005).
38. Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509 (1957).
39. Cui, X. et al. Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy. Diabetes Res Clin Pract 87, 57-63 (2010).
40. Matsuda, K., Tsuji, H., Asahara, T., Kado, Y. & Nomoto, K. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 73, 32-39 (2007).
41. Matsuda, K. et al. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 75, 1961-1969 (2009).